Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab

Rosenblat, T. L., McDevitt, M. R., Carrasquillo, J. A., Pandit-Taskar, N., Frattini, M. G., Maslak, P. G., Park, J. H., Douer, D., Cicic, D., Larson, S. M., Scheinberg, D. A., & Jurcic, J. G. (2022). Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab. Clinical Cancer Research, 28(10), 2030–2037. https://doi.org/10.1158/1078-0432.ccr-21-3712
Authors:
Todd L. Rosenblat
Michael R. McDevitt
Jorge A. Carrasquillo
Neeta Pandit-Taskar
Mark G. Frattini
Peter G. Maslak
Jae H. Park
Dan Douer
Dragan Cicic
Steven M. Larson
David A. Scheinberg
Joseph G. Jurcic
Affiliated Authors:
Todd L. Rosenblat
Joseph G. Jurcic
Publication Type:
Article
Unique ID:
10.1158/1078-0432.CCR-21-3712
PMID:
Publication Date:
Data Source:
Scopus

Record Created: